Idexx Laboratories Lease Liability Payments - Due Year Two decreased by 15.9% to $24.45M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $22.39M to $24.45M. This is a positive signal — lower values indicate better performance for this metric.
Provides insight into the company's fixed cost commitments and long-term operational leverage.
The projected cash payments for operating and finance leases scheduled for the second year following the balance sheet d...
Standard disclosure for lease maturity profiles.
lease_liability_payments_due_year_2| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $18.92M | $20.20M | $18.03M | $19.66M | $19.69M | $18.50M | $20.17M | $22.84M | $23.06M | $24.36M | $26.20M | $22.39M | $27.27M | $29.09M | $24.45M |
| QoQ Change | — | +6.8% | -10.7% | +9.0% | +0.2% | -6.1% | +9.1% | +13.2% | +1.0% | +5.6% | +7.6% | -14.5% | +21.8% | +6.7% | -15.9% |
| YoY Change | — | — | — | +3.9% | -2.5% | +2.6% | +2.6% | +16.0% | +24.7% | +20.8% | +14.7% | -2.9% | +12.0% | +11.0% | +9.2% |